D. J. Garland

发表

1,2‐Diarylcyclopentenes as Selective Cyclooxygenase‐2 Inhibitors and Orally Active anti‐Inflammatory Agents.

C. Koboldt, K. Seibert, P. Isakson, 1996 .

Design, synthesis, and biological evaluation of pyrazinones containing novel P1 needles as inhibitors of TF/VIIa.

D. J. Garland, D. Reitz, Wei Huang, 2007, Bioorganic & medicinal chemistry letters.

Discovery of potent, nonsystemic apical sodium-codependent bile acid transporter inhibitors (Part 2).

D. J. Garland, E. Reinhard, D. Reitz, 2005, Journal of medicinal chemistry.

Discovery of potent, nonsystemic apical sodium-codependent bile acid transporter inhibitors (Part 1).

D. J. Garland, E. Reinhard, D. Reitz, 2005, Journal of medicinal chemistry.

1,2-Diarylcyclopentenes as selective cyclooxygenase-2 inhibitors and orally active anti-inflammatory agents.

C. Koboldt, P. Isakson, S. Gregory, 1995, Journal of medicinal chemistry.

Discovery of (3S,3aR)-2-(3-chloro-4-cyanophenyl)-3-cyclopentyl-3,3a,4,5-tetrahydro-2H-benzo[g]indazole-7-carboxylic acid (PF-3882845), an orally efficacious mineralocorticoid receptor (MR) antagonist for hypertension and nephropathy.

M. Heron, J. Collins, D. J. Garland, 2010, Journal of medicinal chemistry.

The N-Boc Group as an Activator for the a-Lithiation of Carbamates: Synthesis of 11-Substituted Dibenzoxazepines

J. Collins, D. J. Garland, M. B. Norton, 1994 .

Discovery of novel cyanodihydropyridines as potent mineralocorticoid receptor antagonists.

M. Heron, J. Collins, D. J. Garland, 2010, Journal of medicinal chemistry.

Characterization of 3-carboxy-5-phosphono-1,2,3,4-tetrahydroisoquinoline (SC-48981), a potent competitive N-methy-d-aspartate (NMDA) receptor antagonist, in vitro and in vivo

T. Rao, J. Cler, S. Mick, 1992, Neuroscience Letters.

N1-sterically hindered 2H-imidazol-2-one angiotensin II receptor antagonists: The conversion of surmountable antagonists to insurmountable antagonists

K. Koehler, J. Collins, D. J. Garland, 1993 .

Diarylspiro[2.4]heptenes as orally active, highly selective cyclooxygenase-2 inhibitors: synthesis and structure-activity relationships.

C. Koboldt, K. Seibert, P. Isakson, 1996, Journal of medicinal chemistry.

Products in DrosophiZa

P. Taghert, D. J. Garland, L. E. Schneider, 2004 .

SELECTIVE CYCLOOXYGENASE INHIBITORS : NOVEL 4-SPIRO 1,2-DIARYLCYCLOPENTENES ARE POTENT AND ORALLY ACTIVE COX-2 INHIBITORS

C. Koboldt, K. Seibert, P. Isakson, 1995 .

Discovery of novel cyanodihydropyridines as potent mineralocorticoid receptor antagonists.

M. Heron, J. Collins, D. J. Garland, 2010, Journal of medicinal chemistry.

Stereochemical requirements for the mineralocorticoid receptor antagonist activity of dihydropyridines.

J. Collins, D. J. Garland, J. Blinn, 2010, Journal of medicinal chemistry.